Peoples Bancorp (PEBO)
NASDAQ:PEBO
Want to see PEBO full AI Analyst Report?
Top Page
Peoples Bancorp
(NASDAQ:PEBO)
Select Model
Select Model
Rating:77Outperform
Price Target:
$39.00
▲(13.50% Upside)
Action:Reiterated
Date:05/04/26
PEBO scores well primarily on solid financial fundamentals (profitability, cash generation, and manageable leverage) and attractive valuation (low P/E and high dividend yield). Technicals are supportive with the stock above key moving averages, while the earnings call added upside from constructive 2026 guidance and an accretive M&A plan, tempered by credit-cost and deposit-timing risks.
Positive Factors
Strong cash generation
Consistent free cash flow (~92% of net income TTM) and positive operating cash flow underpin the bank’s ability to fund dividends, organic growth, and M&A without heavy external financing. Durable cash generation supports capital returns and cushions earnings volatility over the medium term.
Negative Factors
Elevated credit costs
Higher provisioning and recurring small‑ticket lease charge‑offs point to persistent asset quality pressure. Sustained elevated net charge‑offs increase reserve needs and compress net income and capital formation, making long‑term earnings more sensitive to macro or sector stress.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Consistent free cash flow (~92% of net income TTM) and positive operating cash flow underpin the bank’s ability to fund dividends, organic growth, and M&A without heavy external financing. Durable cash generation supports capital returns and cushions earnings volatility over the medium term.
Read all positive factors
Peoples Bancorp (PEBO) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.23B
Dividend Yield5.3%
Average Volume (3M)262.81K
Price to Earnings (P/E)9.9
Beta (1Y)0.78
Revenue Growth0.38%
EPS Growth-1.41%
CountryUS
Employees1,460
SectorFinancial
Sector Strength70
IndustryBanks - Regional
Share Statistics
EPS (TTM)3.15
Shares Outstanding35,923,470
10 Day Avg. Volume178,910
30 Day Avg. Volume262,809
Financial Highlights & Ratios
PEG Ratio-1.06
Price to Book (P/B)0.87
Price to Sales (P/S)1.70
P/FCF Ratio8.16
Enterprise Value/Market Cap1.48
Enterprise Value/Revenue3.04
Enterprise Value/Gross Profit4.54
Enterprise Value/Ebitda14.66
Forecast
1Y Price Target
$39.00Price Target Upside13.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)3.42
Revenue Forecast (FY)$489.08M
Peoples Bancorp Business Overview & Revenue Model
Company Description
Peoples Bancorp Inc. operates as the holding company for Peoples Bank that provides commercial and retail banking products and services. The company accepts various deposit products, including demand deposit accounts, savings accounts, money marke...
How the Company Makes Money
Peoples Bancorp primarily makes money through traditional banking spread income and fee-based financial services. A major revenue driver is net interest income: the bank earns interest and fees on loans (such as commercial and industrial loans, co...
Peoples Bancorp Earnings Call Summary
Earnings Call Date:Apr 21, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Jul 28, 2026
Earnings Call Sentiment Positive
The call presented a generally positive operational and strategic picture: quarterly EPS beat, NIM expansion, strong deposit inflows, loan growth (notably in C&I), improved asset quality metrics and capital ratios, plus an accretive M&A announcement expected to deliver cost savings and EPS accretion. Offsetting items included higher provisions driven by macro assumptions, continued elevated net charge-offs (notably small-ticket lease losses), one-time first-quarter expenses that pressured reported efficiency, and some seasonal funding timing risk. On balance the positive financial results, capital strength, and strategic deal that is expected to be accretive and improve efficiency outweigh the near-term credit and expense headwinds.Positive Updates
Earnings Per Share Beat
Diluted EPS of $0.81 for Q1 2026, exceeding consensus of $0.80 (beat of $0.01).
Negative Updates
Higher Provision for Credit Losses
Provision for credit losses of $9.7 million for the quarter increased allowance for credit losses to 1.16% of loans from 1.12% at year-end, driven by deterioration in macroeconomic inputs to models.
Read all updates
Q1-2026 Updates
Positive
Negative
Earnings Per Share Beat
Diluted EPS of $0.81 for Q1 2026, exceeding consensus of $0.80 (beat of $0.01).
Read all positive updates
Company Guidance
Management guided full‑year 2026 (ex‑noncore and excluding the proposed Citizens merger) to positive operating leverage versus 2025 and a net interest margin of about 4.42% for the year (stated on the call as 44.2%), with NIM moving ~3–4 basis points for each 25 bp Fed move; they expect quarterly fee‑based income of $28–30 million, quarterly noninterest expense of $73–75 million for the remaining periods of 2026, loan growth toward the low end of a 3–5% annual range, and a slight reduction in net charge‑offs versus 2025 (Q2 charge‑offs expected to be consistent with recent quarters). Regarding the Citizens transaction (≈$77 million consideration for a $700 million‑asset bank with 12 branches), management expects a tangible book earn‑back of <1 year, ~40% cost savings (≈50% realized in 2026 and the remainder early 2027), improvement in regulatory capital ratios at close, and $0.20 accretion to 2027 EPS; they also noted Durbin exposure of about $10 million pretax (≈$1 million attributable to Citizens).Peoples Bancorp Financial Statement Overview
Summary
Income Statement
73
Positive
Balance Sheet
71
Positive
Cash Flow
78
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 598.90M | 618.38M | 615.90M | 522.50M | 339.77M | 244.30M |
| Gross Profit | 401.04M | 417.15M | 419.04M | 407.30M | 327.17M | 231.33M |
| EBITDA | 124.37M | 134.81M | 152.98M | 148.79M | 145.96M | 81.61M |
| Net Income | 111.45M | 106.78M | 117.20M | 113.36M | 101.29M | 47.55M |
Balance Sheet | ||||||
| Total Assets | 9.65B | 9.65B | 9.25B | 9.16B | 7.21B | 7.06B |
| Cash, Cash Equivalents and Short-Term Investments | 112.28M | 188.95M | 1.30B | 1.48B | 1.29B | 1.69B |
| Total Debt | 691.29M | 734.42M | 431.55M | 733.74M | 601.23M | 265.96M |
| Total Liabilities | 8.43B | 8.44B | 8.14B | 8.10B | 6.42B | 6.22B |
| Stockholders Equity | 1.22B | 1.21B | 1.11B | 1.05B | 785.33M | 845.02M |
Cash Flow | ||||||
| Free Cash Flow | 123.63M | 128.70M | 136.37M | 130.19M | 113.09M | 149.74M |
| Operating Cash Flow | 134.97M | 134.73M | 143.19M | 143.64M | 119.84M | 156.42M |
| Investing Cash Flow | -430.27M | -424.45M | -344.31M | -132.93M | -414.21M | -74.43M |
| Financing Cash Flow | 286.10M | 261.01M | -7.94M | 261.99M | 32.67M | 181.64M |
Peoples Bancorp Technical Analysis
Positive
34.36
Price Trends
33.16
Positive
32.39
Positive
30.63
Positive
Market Momentum
0.16
Negative
59.81
Neutral
79.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PEBO, the sentiment is Positive. The current price of 34.36 is above the 20-day moving average (MA) of 33.90, above the 50-day MA of 33.16, and above the 200-day MA of 30.63, indicating a bullish trend. The MACD of 0.16 indicates Negative momentum. The RSI at 59.81 is Neutral, neither overbought nor oversold. The STOCH value of 79.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PEBO.
Peoples Bancorp Risk Analysis
Peoples Bancorp disclosed 40 risk factors in its most recent earnings report. Peoples Bancorp reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Peoples Bancorp Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $1.23B | 9.95 | 9.37% | 5.30% | 0.38% | -1.41% | |
77 Outperform | $1.46B | 11.58 | 6.53% | 1.56% | -2.72% | 5.89% | |
75 Outperform | $1.23B | 10.77 | 19.50% | 3.39% | -12.54% | 126.82% | |
73 Outperform | $1.20B | 10.08 | 12.27% | 3.44% | 8.48% | 19.55% | |
70 Outperform | $1.08B | 12.55 | 4.22% | 4.05% | 2.01% | -23.22% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $1.59B | 11.76 | 8.43% | ― | 6.06% | 9.55% |
* Financial Sector Average
PEBO
Peoples Bancorp
34.62
6.71
24.02%
OCFC
Oceanfirst Financial
18.80
2.74
17.08%
TMP
Tompkins Financial Corporation
86.12
27.33
46.49%
CTBI
Community Bancorp
67.00
17.65
35.78%
OBK
Origin Bancorp
47.59
15.04
46.22%
FSUN
FirstSun Capital Bancorp
35.97
0.37
1.04%
Peoples Bancorp Corporate Events
Business Operations and StrategyFinancial Disclosures
Peoples Bancorp Plans Investor Meetings to Highlight Strategy
Positive
May 4, 2026
Between May 4, 2026 and June 30, 2026, Peoples Bancorp Inc.’s management team, including its President and Chief Executive Officer and its Executive Vice President, Chief Financial Officer and Treasurer, planned to hold one or more meetings ...
Executive/Board ChangesShareholder Meetings
Peoples Bancorp Shareholders Back Board, Pay and Auditor
Positive
Apr 28, 2026
On April 23, 2026, Peoples Bancorp Inc. held its 2026 Annual Meeting of Shareholders, with about 77% of eligible common shares represented in person or by proxy. Shareholders elected eleven directors to one-year terms, reflecting broad support for...
Business Operations and StrategyDividendsFinancial DisclosuresM&A Transactions
Peoples Bancorp to Acquire Citizens National Corporation
Positive
Apr 21, 2026
On April 21, 2026, Peoples Bancorp reported first-quarter 2026 net income of $29.0 million, or $0.81 per diluted share, down from $31.8 million in the prior quarter but up from $24.3 million a year earlier, driven by higher net interest income and...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.